Skip to content

Merck set to be top in pharma licensing deals for 2018, according to GlobalData

Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016.

Merck set to be top in pharma licensing deals for 2018, according to GlobalData
Published: | 1 min read

Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016.

Success

Within the pharmaceutical industry, companies’ financial success is often linked with the strategic deals they make with other companies or research organisations to enable the development of the next market leading drug.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information